Bio-Works Technologies AB (publ) (BIOWKS.ST)

2.9400 -0.0600 (-2.00%) At close: 05:17PM CEST

Bio-Works Technologies AB (publ)

Virdings allé 18
Uppsala 754 50
Sweden
46 8 56 26 74 30
https://www.bio-works.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 35

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jonathan Royce	Chief Executive Officer	N/A	N/A	N/A
Mr. Jan Berglöf	Co-Founder & Senior Advisor	N/A	N/A	N/A
Mr. Arne Hauge	Chief Financial Officer	N/A	N/A	N/A
Mr. Karsten Fjärstedt	Chief Operating Officer	N/A	N/A	N/A
Ms. Sara Ekvall	Director of People & Culture	N/A	N/A	N/A
Ms. Helena Pahlm	Senior Director of Global Quality	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.

Corporate governance

Bio-Works Technologies AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.